Trial site
Hospital Universitario Quironsalud Madrid
- 183running trials
- 84closed trials
The trials here
What the 269 trials at this site are about, from their registry records.
- Conditions
- Lung cancer52 trials
- Multiple myeloma24 trials
- Multiple sclerosis17 trials
- Metastatic breast cancer16 trials
- Obesity16 trials
- Alzheimer disease15 trials
- Prostate cancer14 trials
- Bladder cancer13 trials
- Diffuse large B-cell lymphoma11 trials
- Ovarian cancer10 trials
- Type 2 diabetes10 trials
- Atopic dermatitis (eczema)9 trials
- and 49 more
- Phase
- Phase 3142 trials
- Phase 251 trials
- Phase 136 trials
- Phase 1/232 trials
- Phase 2/36 trials
- Phase 41 trial
- Status
- Recruiting86 trials
- Completed81 trials
- Active, not recruiting80 trials
- Not yet recruiting17 trials
- Suspended2 trials
- Terminated2 trials
- Withdrawn1 trial
- Lead sponsor
- Merck Sharp & Dohme LLC35 trials
- Eli Lilly and Company18 trials
- Hoffmann-La Roche17 trials
- GlaxoSmithKline12 trials
- Janssen Research & Development, LLC10 trials
- and 101 more
Running trials
Not yet recruiting
Not yet recruiting
Not yet recruiting
Recruiting
A study to learn about the effects of Trontinemab in participants at risk for Alzheimer‘s disease
Not yet recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Study of an On-Body Injection System for Home Use of Ocrelizumab in People with Multiple Sclerosis
Recruiting
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Recruiting
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
Recruiting
Recruiting
Recruiting
A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
Recruiting
Recruiting
Recruiting
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Validation of the Sentinel Lymph Node Technique in Early-stage Ovarian Cancer (SENTOV II)
Showing 50 of 183.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer25 recruiting
- Prostate cancer10 recruiting
- Ovarian cancer9 recruiting
- Obesity8 recruiting
- Bladder cancer7 recruiting
- Multiple myeloma7 recruiting
- Metastatic breast cancer6 recruiting
- Follicular lymphoma5 recruiting
- Diffuse large B-cell lymphoma4 recruiting
- Endometrial cancer4 recruiting
- Head and neck cancer4 recruiting
- Melanoma4 recruiting
- Obstructive sleep apnoea4 recruiting
- Pancreatic cancer4 recruiting
- Alzheimer disease3 recruiting
- Asthma3 recruiting
- Bronchiectasis3 recruiting
- Chronic lymphocytic leukaemia3 recruiting
- Idiopathic pulmonary fibrosis3 recruiting
- Multiple sclerosis3 recruiting
- Type 2 diabetes3 recruiting
- Acute myeloid leukaemia2 recruiting
- Brain metastases2 recruiting
- Childhood cancers2 recruiting
- COPD2 recruiting
- Cystic fibrosis2 recruiting
- Gastric and oesophageal cancer2 recruiting
- Hodgkin lymphoma2 recruiting
- Kidney cancer2 recruiting
- Mantle cell lymphoma2 recruiting
- Parkinson disease2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Burkitt lymphoma1 recruiting
- Cervical cancer1 recruiting
- Chronic spontaneous urticaria1 recruiting
- Colorectal cancer1 recruiting
- Immune thrombocytopenia (ITP)1 recruiting
- Mesothelioma1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Neuroendocrine tumours1 recruiting
- Sarcoma1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
GSK4527226 Open-label Extension Study in Patients with Early Alzheimer's Disease.
Completed
Active, not recruiting
Phase 1b/2 Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced NSCLC (Substudy NSCLC)
Completed
Active, not recruiting
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
Completed
Active, not recruiting
Completed
Completed
Completed
Terminated
Completed
Completed
EFFICACY AND SAFETY OF GSK4527226 [AL101] IN PATIENTS WITH EARLY ALZHEIMER’S DISEASE
Completed
Completed
Active, not recruiting
Completed
Completed
A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD
Terminated
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Withdrawn
Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 1
Completed
Active, not recruiting
Completed
A Study in Participants With Non-cirrhotic NASH With Fibrosis
Active, not recruiting
Completed
GV1001 Subcutaneous(SC) for the Treatment of Mild to Moderate Alzheimer's Disease (AD)
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)
Active, not recruiting
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
Completed
Completed
Completed
Completed
Completed
A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation
Completed
Showing 50 of 84.
Site data: ClinicalTrials.govUpdated 19 Nov 2026